Status:
UNKNOWN
Effects of Low-level Laser Therapy in the Fatigue Muscle of Healthy Individual and Spastic Individuals
Lead Sponsor:
Universidade do Vale do Paraíba
Conditions:
Fatigue
Stroke Sequelae
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Muscle fatigue is caused by biochemical changes that modify the mechanics of muscle contraction, which result in negative changes in the performance of the contraction. The objective of this study is ...
Detailed Description
Muscle fatigue is caused by biochemical changes that modify the mechanics of muscle contraction, which result in negative changes in the performance of the contraction. Several resources are studied i...
Eligibility Criteria
Inclusion
- Inclusion Criteria (Healthy group):
- Preserved cognition, and preservation of the ability to respond to verbal stimul;
- To present the "insufficient active" or "active" indices on the scale of the International Questionnaire of Physical Activity.
- Inclusion Criteria (Post stroke group):
- Individuals with medical diagnosis of stroke;
- Individuals with physiotherapeutic diagnosis of spastic hemiparesis with brachial predominance;
- Preserved cognition and preservation of the ability to respond to verbal stimuli;
- Injury time: after 12 months;
- Patients with a maximum of 2 degree spasticity according to the Modified Ashworth Scale and minimum muscle strength of 1 in the biceps brachii muscle.
- Exclusion Criteria (Healthy group):
- Possess musculoskeletal impairment of the dominant upper limb;
- Practice physical activity with load (bodybuilding);
- Presence of active infection and eruptions in the dominant upper limb;
- Limiting pain that makes it impossible to perform the evaluation protocol;
- Ingestion of analgesic and / or anti-inflammatory drugs and / or drugs containing corticosteroids or steroids.
- Fitzpatrick classification: Phototypes V and VI;
- Presence of malignant neoplastic lesion;
- Presence of active infection and eruptions at the electrode application site;
- Hypoesthesia and / or hyperesthesia and / or anesthesia of the limb in which TLBI will be applied.
- Exclusion Criteria (Healthy group):
- Presence of active infection and eruptions in the dominant upper limb;
- Limiting pain that makes it impossible to perform the evaluation protocol;
- Ingestion of analgesic and / or anti-inflammatory drugs and / or drugs containing corticosteroids or steroids.
- Fitzpatrick classification: Phototypes V and VI;
- Presence of malignant neoplastic lesion;
- Presence of active infection and eruptions at the electrode application site;
- Hypoesthesia and / or hyperesthesia and / or anesthesia of the limb to be treated;
- Muscular contractures and joint deformities;
- Uncontrolled arterial hypertension;
- Individuals with other associated neurological and / or orthopedic disorders;
- Wernick or Broca's aphasia.
Exclusion
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03753984
Start Date
September 1 2018
End Date
March 1 2020
Last Update
July 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade do Vale do Paraiba
São José dos Campos, São Paulo, Brazil, 12.244-000